Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ASN51 for Alzheimer's Disease
Recruiting0 awardsPhase 2
Clermont, Florida
"This trial aims to test the safety and effectiveness of multiple doses of ASN51 in adults with early Alzheimer's disease. The study will look at how well the drug is tolerated, its effects on disease biom
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.